Reckitt CEO's $17B Predicament Post author:Sam Post published:December 26, 2017 Post category:BioPharma 2018 is the year for Rakesh Kapoor to show he’s worth it. Source: BioSpace You Might Also Like Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017 Bill & Melinda Gates Foundation Bets on This Biotech to Win the Zika Race (Hint, It's a Unicorn) May 21, 2017 Biocept Announces Private Placement Of $2.2 Million Of Common Stock With August 9, 2017
Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
Bill & Melinda Gates Foundation Bets on This Biotech to Win the Zika Race (Hint, It's a Unicorn) May 21, 2017
